TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) Investor Lawsuit Against Acquisition By Eli Lilly and Company Filed

  • If you purchased shares of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) and currently hold any of those NASDAQ:CLCD shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

February 22, 2017 (Shareholders Foundation) - An investor, who currently holds shares of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD), filed a lawsuit in effort to halt the proposed takeover of CoLucid Pharmaceuticals Inc by Eli Lilly and Company for $46.50 per share is unfair to NASDAQ:CLCD stockholders. The plaintiff alleges that the defendants breached their fiduciary duties owed to ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: